01134nas a2200421   4500000000100000008004100001260001600042653002500058653001200083653002500095653001900120653001100139653001700150653002600167653002900193653001900222653001200241653001600253653003600269653000900305653002500314653002800339653002500367653001700392653001200409653001500421653002200436100001500458700001900473700001500492700001300507700001500520700001600535245012800551300001100679490000800690022001400698       1969                            d  c1969 Mar 1510aAdenoma, Pleomorphic10aAnimals10aAntilymphocyte Serum10aBone Neoplasms10aFemale10aFibrosarcoma10aImmunization, Passive10aImmunosuppressive Agents10aLeiomyosarcoma10aleprosy10aLymphocytes10aMammary Neoplasms, Experimental10aMice10aMycobacterium leprae10aNeoplasms, Experimental10aNeutralization Tests10aOsteosarcoma10aSarcoma10aThymectomy10aUterine Neoplasms1 aGaugas J M1 aChesterman F C1 aHirsch M S1 aRees R J1 aHarvey J J1 aGilchrist C00aUnexpected high incidence of tumours in thymectomized mice treated with anti-lymphocytic globulin and Mycobacterium leprae.  a1033-60 v221  a0028-0836